Cargando…
Atrial fibrillation‐related stroke in women: Evidence and inequalities in epidemiology, mechanisms, clinical presentation, and management
BACKGROUND: Atrial fibrillation (AF) is the most common clinical arrhythmia and one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity. Despite substantial advances in (interventional) rhythm control treatment during the last decade, anticoagulation for stroke p...
Autores principales: | Kostopoulou, Anna, Zeljko, Hrvojka M., Bogossian, Harilaos, Ciudin, Radu, Costa, Francisco, Heijman, Jordi, Kochhaeuser, Simon, Manola, Sime, Scherr, Daniel, Sohal, Manav, Wakili, Reza, Wolf, Michael, Irfan, Ghazala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954380/ https://www.ncbi.nlm.nih.gov/pubmed/31691981 http://dx.doi.org/10.1002/clc.23284 |
Ejemplares similares
-
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022) -
Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019) -
Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013) -
Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014) -
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)